• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Castration resistant prostate cancer with drug resistance and tumor microenvironment

Research Project

  • PDF
Project/Area Number 24890230
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionKeio University

Principal Investigator

TAKEO Kosaka  慶應義塾大学, 医学部, 助教 (30445407)

Project Period (FY) 2012-08-31 – 2014-03-31
Keywords前立腺癌 / 血管新生 / アンドロゲン / 去勢抵抗性前立腺癌 / 微小環境 / VASH1 / C4-2AT6
Research Abstract

To reveal tumor microenvironment in Prostate Cancer (PCa), we focused on angiogenesis and androgen production. We examine the expression of VASH1 in PCa specimens. We found VASH1 density represents a clinically relevant predictor of patient prognosis and can be a new biomarker that would provide additional prognostic information in PCa (Kosaka T. et al. Br J Cancer 2013). To ascertain the potential SRD5A activity, we cultured two human CRPC cell lines: C4-2 and C4-2AT6 cells with steroid precursors: 13C-Adione, and analyzed the sequential biosynthesis of 13C-T and 13C-DHT by LC/MS/MS. 13C-DHT concentration in C4-2AT6 cells was significantly lower than C4-2. An increased concentration of DHT did not have a positive effect on cell proliferation. SRD5A inhibitors did not have any inhibitory effect, suggesting CRPC cells may have an unknown regulation system to protect themselves from androgenic suppressive effect mediated by SRD5A activity (Kosaka T. et al. Scientific Rep 2013).

  • Research Products

    (19 results)

All 2014 2013 2012 Other

All Journal Article (8 results) (of which Peer Reviewed: 8 results) Presentation (10 results) Remarks (1 results)

  • [Journal Article] Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy2014

    • Author(s)
      Hattori S, Kosaka T, Mizuno R, Kanao K, Miyajima A, Yasumizu Y, Yazawa S, Nagata H, Kikuchi E, Mikami S, Jinzaki M, Nakagawa K, Tanimoto A, Oya M
    • Journal Title

      BJU Int

      Volume: 113(5) Pages: 741-7

    • DOI

      10.1111/bju.12329

    • Peer Reviewed
  • [Journal Article] Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer2014

    • Author(s)
      Yasumizu Y, Miyajima A, Kosaka T, Miyazaki Y, Kikuchi E, Oya M
    • Journal Title

      J Urol

      Volume: 191(1) Pages: 227-34

    • DOI

      10.1016/j.juro.2013.07.101

    • Peer Reviewed
  • [Journal Article] Invasion and metastasis of renal cell carcinoma2013

    • Author(s)
      Mikami S, Oya M, Mizuno R, Kosaka T, Katsube KI, Okada Y
    • Journal Title

      Med Mol Morphol

    • Peer Reviewed
  • [Journal Article] Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming2013

    • Author(s)
      Kosaka T, Nagamatsu G, Saito S, Oya M, Suda T, Horimoto K
    • Journal Title

      Cancer Sci

      Volume: 104(8) Pages: 1017-26

    • DOI

      10.1111/cas.12183

    • Peer Reviewed
  • [Journal Article] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma2013

    • Author(s)
      Yoshimine S, Kikuchi E, Kosaka T, Mikami S, Miyajima A, Okada Y, Oya M
    • Journal Title

      Br J Cancer

      Volume: 108(11) Pages: 2312-20

    • DOI

      10.1038/bjc.2013.216

    • Peer Reviewed
  • [Journal Article] The prognostic significance of vasohibin-1 expression in patients with prostate cancer2013

    • Author(s)
      Kosaka T, Miyazaki Y, Miyajima A, Mikami S, Hayashi Y, Tanaka N, Nagata H, Kikuchi E, Nakagawa K, Okada Y, Sato Y, Oya M
    • Journal Title

      Br J Cancer

      Volume: 108(10) Pages: 2123-9

    • DOI

      10.1038/bjc.2013.169

    • Peer Reviewed
  • [Journal Article] Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity2013

    • Author(s)
      Kosaka T, Miyajima A, Nagata H, Maeda T, Kikuchi E, Oya M
    • Journal Title

      Sci Rep

      Pages: 1268

    • DOI

      10.1038/srep01268

    • Peer Reviewed
  • [Journal Article] Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells2013

    • Author(s)
      8: Suzuki K, Mizuno R, Suenaga K, Teruya T, Tanaka N, Kosaka T, Oya M
    • Journal Title

      Cancer Med

      Volume: 2(1) Pages: 32-9

    • DOI

      10.1002/cam4.53

    • Peer Reviewed
  • [Presentation] 前立腺癌における新規血管新生マーカーの発現の検討2013

    • Author(s)
      小坂威雄,宮崎保匡,宮嶋哲、三上修治,安水洋太,菊地栄次,田中川健,岡田保典,佐藤靖史,大家基嗣
    • Organizer
      第29回前立腺シンポジウム
    • Place of Presentation
      東京品川コンベンションセンター
    • Year and Date
      2013-12-14
  • [Presentation] PI3K-mTORシグナル阻害剤は去勢抵抗性前立腺癌においてドセタキセルへの感受性を増大させる2013

    • Author(s)
      安水洋太,宮嶋哲,小坂威雄,宮崎保匡、菊地栄次,大家基嗣
    • Organizer
      第72回日本癌学会総会
    • Place of Presentation
      横浜パシフィコ横浜
    • Year and Date
      2013-10-05
  • [Presentation] 上部尿路上皮癌における新規血管新生制御因子Vasohibin-1発現の臨床的意義2013

    • Author(s)
      宮崎保匡,小坂威雄,三上修治,菊地栄次,田中伸之,前田高宏,石田勝,宮嶋哲,中川健,岡田保典,佐藤靖史,大家基嗣
    • Organizer
      日本癌治療学会
    • Place of Presentation
      横浜パシフィコ横浜
    • Year and Date
      2013-09-14
  • [Presentation] 去勢抵抗性前立腺癌におけるアンドロゲン産生系の生化学的解析2013

    • Author(s)
      小坂威雄,宮嶋哲,安水洋太,菊地栄次,大家基嗣
    • Organizer
      第32回アンドロロジー学会
    • Place of Presentation
      大阪グランキューブ大阪
    • Year and Date
      2013-07-26
  • [Presentation] A new strategy for castration resistant prostate cancer with targeting to feedback mechanisms of PI3K/AKT/mTOR pathway2013

    • Author(s)
      5: Yasumizu Y, Miyajima A, Kosaka T, Kikuchi E, Oya M
    • Organizer
      American Urological Association Annual Meeting
    • Place of Presentation
      Sandiego USA
    • Year and Date
      2013-05-06
  • [Presentation] Intracrine dynamics of CYP17A1 activities in human castration resistant prostate cancer2013

    • Author(s)
      Kosaka T, Miyajima A, Nagata H, Maeda T,Kikuchi E, Oya M
    • Organizer
      American Urological Association Annual Meeting
    • Place of Presentation
      Sandiego USA
    • Year and Date
      2013-05-05
  • [Presentation] アンドロゲン産生系に着目した去勢抵抗性前立腺癌の生化学的解析2013

    • Author(s)
      小坂威雄,宮嶋哲,長田浩彦、前田高宏、安水洋太,菊地栄次,大家基嗣
    • Organizer
      第101回日本泌尿器科学会総会
    • Place of Presentation
      札幌ロイトン札幌
    • Year and Date
      2013-04-25
  • [Presentation] 去勢抵抗性前立腺癌に対するPI3K・mTORC1/2阻害剤とドセタキセル併用効果についての検討(Combination Therapy with PI3K-mTOR Pathway Inhibitor and Docetaxel in Castration Resistant Prostate Cancer)2012

    • Author(s)
      安水洋太,宮嶋哲,小坂威雄,城武卓,菊地栄次,大家基嗣
    • Organizer
      第71回日本癌学会総会
    • Place of Presentation
      札幌ロイトン札幌
    • Year and Date
      2012-09-20
  • [Presentation] 上部尿路上皮癌におけるVasohibin-1の発現に関する予後因子として検討(The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma)2012

    • Author(s)
      宮崎保匡,小坂威雄,三上修治,菊地栄次,田中伸之,前田高宏,石田勝,宮嶋哲,中川健,岡田保典,佐藤靖史,大家基嗣
    • Organizer
      第71回日本癌学会総会
    • Place of Presentation
      札幌ロイトン札幌
    • Year and Date
      2012-09-20
  • [Presentation] 去勢抵抗性前立腺癌におけるCYP17A1活性(Direct evidence of dual CYP17A1 activities in human castration resistant prostate cancer)2012

    • Author(s)
      小坂威雄,宮嶋哲,菊地栄次,大家基嗣
    • Organizer
      第71回日本癌学会総会
    • Place of Presentation
      札幌ロイトン札幌
    • Year and Date
      2012-09-20
  • [Remarks]

    • URL

      http://www.keio-urology.jp/

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi